Evofem Biosciences (EVFM.US): The 2024 Q1 financial report achieved revenue of US$3.603 million, previous value of US$5.809 million; earnings per share were -0.16 USD, previous value of -1.85 USD.
Evofem Biosciences(EVFM.US)：2024年Q1财报实现营收360.3万美元，前值为580.9万美元；每股收益为-0.16美元，前值为-1.85美元。
Evofem Biosciences (EVFM.US): The 2024 Q1 financial report achieved revenue of US$3.603 million, previous value of US$5.809 million; earnings per share were -0.16 USD, previous value of -1.85 USD.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.